TrialClinical and translational science2019

Exposure-Response Modeling and Simulation of Progression-Free Survival and Adverse Events of Sorafenib Treatment in Patients With Advanced Thyroid Cancer.

Joachim Grevel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.